Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Market Closed 10-16 16:00:00 EDT

4.52

+0.19

+4.39%

盘后4.58

+0.06+1.41%

19:30 EDT

High4.72	Low4.22	Vol1.07M
Open4.35	D1 Closing4.33	Amplitude11.55%
Mkt Cap87.42M	Tradable Cap59.88M	Total Shares19.34M
T/O4.81M	T/O Rate8.04%	Tradable Shares13.25M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":4.52,"timestamp":1792180800000,"preClose":4.33,"halted":0,"volume":1065388,"hourTrading":{"tag":"盘后","latestPrice":4.5837,"preClose":4.52,"latestTime":"19:30 EDT","volume":4946,"amount":22387.5438,"timestamp":1792193404422,"change":0.0637,"changeRate":0.014093,"amplitude":0.014093},"delay":0,"changeRate":0.043879907621247,"floatShares":13248200,"shares":19341300,"eps":-6.088859,"marketStatus":"Market Closed","change":0.19,"latestTime":"10-16 16:00:00 EDT","open":4.35,"high":4.72,"low":4.2201,"amount":4813726.61958,"amplitude":0.11545,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.088859,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1792396800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.33,"preHourTrading":{"tag":"盘前","latestPrice":4.35,"preClose":4.33,"latestTime":"09:10 EDT","volume":119,"amount":520.0551804,"timestamp":1792156250231,"change":0.02,"changeRate":0.004619,"amplitude":0.166282},"postHourTrading":{"tag":"盘后","latestPrice":4.5837,"preClose":4.52,"latestTime":"19:30 EDT","volume":4946,"amount":22387.5438,"timestamp":1792193404422,"change":0.0637,"changeRate":0.014093,"amplitude":0.014093},"volumeRatio":1.07223292058275,"impliedVol":1.8535,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/CRBP/tweets","defaultTab":"tweets","newsList":[{"id":"2675355891","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675355891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675355891?lang=en_us&edition=fundamental","pubTime":"2026-10-16 05:18","pubTimestamp":1792099080,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.81% to $4.33 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.08% to 26,713.03 and the Dow Jones Industrial Average  rising 1.08% to 52,177.69.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 78.94% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  rose 0.47% to $4.24, Fortress Biotech Inc.  rose 0.53% to $1.91, and Viking Therapeutics Inc.  rose 7.46% to $27.37.Trading volume  eclipsed its 50-day average volume of 955,151.Data source: Dow Jones Market Data, FactSet. Data comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675535430","title":"Corbus Pharmaceuticals Updates Oncology and Obesity Pipeline Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2675535430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675535430?lang=en_us&edition=fundamental","pubTime":"2026-10-15 22:48","pubTimestamp":1792075692,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals ( ($CRBP) ) has provided an announcement. On October 15, 2026, Corbus Pharmaceuticals updated its corporate presentation out...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-updates-oncology-and-obesity-pipeline-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbus-pharmaceuticals-updates-oncology-and-obesity-pipeline-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675606383","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675606383","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675606383?lang=en_us&edition=fundamental","pubTime":"2026-10-14 05:21","pubTimestamp":1791926460,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 9.30% to $4.78 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 0.15% to 27,204.38 and Dow Jones Industrial Average  falling 0.35% to 51,670.10.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 76.75% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 5.29% to $4.30, Fortress Biotech Inc.  fell 7.58% to $1.95, and Viking Therapeutics Inc.  fell 5.96% to $26.65.Trading volume  remained 274,916 below its 50-day average volume of 923,194.Data source: Dow Jones Market Data, FactSet. Dat","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675883253","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2675883253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675883253?lang=en_us&edition=fundamental","pubTime":"2026-10-13 05:19","pubTimestamp":1791839940,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 2.04% to $5.27 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.38% to 51,850.55 and the NASDAQ Composite Index  falling 0.44% to 27,245.90.Corbus Pharmaceuticals Holdings Inc. closed 74.37% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  fell 0.66% to $4.54, Fortress Biotech Inc.  fell 1.17% to $2.11, and Viking Therapeutics Inc.  fell 0.60% to $28.34.Trading volume  eclipsed its 50-day average volume of 910,013.Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674586590","title":"Corbus’s CRB-913 Obesity Trial Reaches Key Phase 1b Milestone, Putting CRBP on Investors’ Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2674586590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674586590?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563461,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings ($CRBP) announced an update on their ongoing clinical study. Corbus Pharmaceuticals Inc. is advancing its obesity p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/corbuss-crb-913-obesity-trial-reaches-key-phase-1b-milestone-putting-crbp-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/corbuss-crb-913-obesity-trial-reaches-key-phase-1b-milestone-putting-crbp-on-investors-radar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ISBC","CRBP","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888265","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888265","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888265?lang=en_us&edition=fundamental","pubTime":"2026-10-09 05:19","pubTimestamp":1791494340,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 4.01% to $5.27 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.10% to 51,231.64 and the NASDAQ Composite Index  falling 1.25% to 27,193.34.This was the stock's sixth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 74.37% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 0.66% to $4.53, Fortress Biotech Inc.  rose 2.45% to $2.09, and Viking Therapeutics Inc.  fell 2.84% to $27.73.Trading volume  eclipsed its 50-day average volume of 873,687.Data source: Dow Jones Market Data, FactSet. Data compiled ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065049","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065049","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065049?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:21","pubTimestamp":1791321660,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.20% to $5.78 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.45% to 27,599.79 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 71.89% short of its 52-week high of $20.56, which the company achieved on October 20th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 1.31% to $4.52, Fortress Biotech Inc.  fell 1.91% to $2.05, and Viking Therapeutics Inc.  fell 3.07% to $28.38.Trading volume  remained 138,503 below its 50-day average volume of 845,062.Data source: Dow Jones Market Data, FactSe","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084619","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084619","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084619?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:34","pubTimestamp":1791232440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.6% to $5.85 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 71.5% below its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 1.1% to $4.58, Fortress Biotech Inc. rose 3.0% to $2.09, and Viking Therapeutics Inc. fell 2.20% to $29.28.Trading volume totaled 783,291, compared to the 50-day average of 832,647.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741504","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741504?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:21","pubTimestamp":1790976060,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slipped 3.31% to $6.13 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 1.19% to 27,190.86 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 70.18% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 3.74% to $4.63, Fortress Biotech Inc.  fell 1.93% to $2.03, and Viking Therapeutics Inc.  fell 1.87% to $29.94.Trading volume  eclipsed its 50-day average volume of 828,735.Data source: Dow Jones Market Data, FactS","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787019","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787019","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787019?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:22","pubTimestamp":1790803320,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.87% to $6.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.24% to 26,861.06 and the Dow Jones Industrial Average  falling 0.86% to 50,906.05.The stock's rise snapped a five-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 66.83% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 2.39% to $4.91, Fortress Biotech Inc.  fell 2.73% to $2.14, and Viking Therapeutics Inc.  rose 2.48% to $32.60.Trading volume  remained 300,620 below its 50-day average volume of 807,220.Data source: Dow Jones Market Data, FactSet. Data compiled Septe","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211398","title":"Corbus Pharmaceuticals Announces First Patient Dosed in Tempo-1 Registrational Study of Crb-701 in Patients with 2L+ Oropharyngeal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211398?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUAFLNLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671644268","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671644268","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671644268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:22","pubTimestamp":1790630520,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 3.08% to $6.92 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 0.92% to 26,820.38 and Dow Jones Industrial Average  falling 0.67% to 51,481.51.This was the stock's fourth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 66.34% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 2.38% to $5.17, Fortress Biotech Inc.  fell 4.82% to $2.17, and Viking Therapeutics Inc.  fell 7.11% to $33.03.Trading volume  eclipsed its 50-day average volume of 781,367.Data source: Dow Jones Market Data, FactSet. Da","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670247784","title":"Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670247784","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670247784?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:34","pubTimestamp":1790368440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.2% to $7.14 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 27,068.72 and the Dow Jones Industrial Average rising 0.9% to 51,828.62.This was the stock's third consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 65.3% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 1.4% to $5.05, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 3.24% to $35.56.Trading volume totaled 686,852, compared to the 50-day average of 771,772.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669282439","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669282439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669282439?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:20","pubTimestamp":1790198400,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  slid 1.71% to $7.74 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.The stock's fall snapped a three-day winning streak.Corbus Pharmaceuticals Holdings Inc. closed 62.35% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  fell 3.26% to $5.04, Fortress Biotech Inc.  fell 4.49% to $2.34, and Viking Therapeutics Inc.  rose 1.96% to $41.65.Trading volume  eclipsed its 50-day average volume of 753,070.Data source: Dow Jones Market Data, FactSet. D","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669930891","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669930891","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669930891?lang=en_us&edition=fundamental","pubTime":"2026-09-22 05:20","pubTimestamp":1790025600,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.27% to $7.65 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.26% to 27,122.09 and the Dow Jones Industrial Average  rising 0.71% to 52,048.83.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 62.79% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 0.49% to $5.16, Fortress Biotech Inc.  fell 3.98% to $2.41, and Viking Therapeutics Inc.  rose 3.86% to $30.11.Trading volume  remained 246,938 below its 50-day average volume of 745,581.Data source: Dow Jones Mark","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668756009","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668756009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668756009?lang=en_us&edition=fundamental","pubTime":"2026-09-19 05:19","pubTimestamp":1789766340,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 3.03% to $7.48 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.39% to 26,522.55 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.Corbus Pharmaceuticals Holdings Inc. closed 63.62% below its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Friday, as Vanda Pharmaceuticals Inc.  rose 0.39% to $5.13, Fortress Biotech Inc.  remained unchanged, and Viking Therapeutics Inc.  fell 1.26% to $28.99.Trading volume  eclipsed its 50-day average volume of 727,083.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668293559","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rallies 4.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2668293559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668293559?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:34","pubTimestamp":1789590840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. advanced 4.9% to $7.26 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 25,978.42 and the Dow Jones Industrial Average falling 1.2% to 51,461.90.The stock's rise snapped an eight-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 64.7% below its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 0.2% to $5.00, Fortress Biotech Inc. fell 1.2% to $2.46, and Viking Therapeutics Inc. fell 1.44% to $29.52.Trading volume totaled 1.2 million, compared to the 50-day average of 703,035.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667240776","title":"Corbus Pharmaceuticals Holdings Inc. Stock Slides 14.4%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667240776","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667240776?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:33","pubTimestamp":1789504380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. tumbled 14.4% to $6.92 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.8% to 25,981.57 and Dow Jones Industrial Average falling 0.6% to 52,093.11.This was the stock's eighth consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 66.3% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 3.1% to $4.99, Fortress Biotech Inc. fell 1.6% to $2.49, and Viking Therapeutics Inc. fell 5.01% to $29.95.Trading volume totaled 3.7 million, compared to the 50-day average of 633,169.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667364291","title":"Wedbush Keeps Their Buy Rating on Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667364291","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667364291?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474532,"startTime":"0","endTime":"0","summary":"Wedbush analyst Robert Driscoll reiterated a Buy rating on Corbus Pharmaceuticals today and set a price target of $30.00. According to TipRanks, Dr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667409","title":"Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667409?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:10","pubTimestamp":1789402226,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corbus Pharmaceuticals (CRBP) and Definium Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-corbus-pharmaceuticals-crbp-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4581","XBI","LU0128526141.USD","BK4139","LU0029874061.USD","BK4585","DFTX","HCSG","BK4007","CRBP","XLV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.1599},{"period":"1month","weight":-0.3774},{"period":"3month","weight":-0.4983},{"period":"6month","weight":-0.5732},{"period":"1year","weight":-0.7627},{"period":"ytd","weight":-0.4447}],"compareEarnings":[{"period":"1week","weight":-0.0197},{"period":"1month","weight":0.0122},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.0748},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1193}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.046477},{"month":5,"riseRate":0.583333,"avgChangeRate":0.055971},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.044414},{"month":7,"riseRate":0.25,"avgChangeRate":-0.049826},{"month":8,"riseRate":0.666667,"avgChangeRate":0.105723},{"month":9,"riseRate":0.25,"avgChangeRate":-0.110488},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.142043},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}